SCHEMBL23183523

SCHEMBL23183523

CSc1[nH]c(=O)cc(-c2cccs2)c1C#N

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.58
▸ PIM1 P11309 5/20 0.58
▸ MAPT P10636 5/20 0.53
▸ ALDH1A1 P00352 7/20 0.52
▸ NPSR1 Q6W5P4 4/20 0.52
▸ RXFP1 Q9HBX9 3/20 0.52
▸ PRNP P04156 2/20 0.52
▸ HPGD P15428 5/20 0.49
▸ HSD17B10 Q99714 3/20 0.49
▸ CYP1A2 P05177 2/20 0.49
▸ CYP2C19 P33261 2/20 0.49
▸ TSHR P16473 2/20 0.49
▸ LMNA P02545 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ ADORA2A P29274 4/20 0.49
▸ ADORA1 P30542 4/20 0.49
▸ ADORA2B P29275 1/20 0.44
▸ GAA P10253 3/20 0.44
▸ GLA P06280 2/20 0.44
▸ CASP1 P29466 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26847344 0.79 NPSR1 (0.52) KDM4EPIM1MAPTALDH1A1NPSR1
SCHEMBL20350814 0.79 KDM4E (0.62) KDM4EPIM1MAPTALDH1A1NPSR1
SCHEMBL26847199 0.78 ACMSD (0.48) KDM4EPIM1MAPTALDH1A1NPSR1
SCHEMBL24087957 0.78 LMNA (0.49) KDM4EPIM1MAPTALDH1A1NPSR1
SCHEMBL26847345 0.78 KDM4E (0.46) KDM4EPIM1MAPTALDH1A1NPSR1
SCHEMBL23183455 0.77 ATM (0.54) KDM4EPIM1MAPTALDH1A1NPSR1
SCHEMBL24087956 0.75 KDM4E (0.46) KDM4EPIM1MAPTALDH1A1NPSR1
SCHEMBL28602629 0.75 KDM4E (0.72) KDM4EPIM1MAPTALDH1A1NPSR1
SCHEMBL24087881 0.74 KDM4E (0.45) KDM4EPIM1MAPTALDH1A1NPSR1
SCHEMBL26847351 0.74 KDM4E (0.45) KDM4EPIM1MAPTALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780812-B2 Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors ORSOBIO, INC. (US) 2023-10-10 — — US disclosed
US-20210094916-A1 OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS ORSOBIO, INC. 2021-04-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210094916-A1 OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS ALDH7A1, OTC, DDC KDM4E 1198/4885PIM1 4067/4885MAPT 3158/4885
US-11780812-B2 Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors ALDH7A1, ACMSD, AMD1 KDM4E 1040/4885PIM1 3802/4885MAPT 2985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback